Avenue Therapeutics, Inc.Avenue Therapeutics, Inc.Avenue Therapeutics, Inc.

Avenue Therapeutics, Inc.

No trades
See on Supercharts

Price target

56.250.00 0.00%
The 1 analyst offering 1 year price forecasts for ATXI have a max estimate of — and a min estimate of —.

Analyst rating

Based on 1 analyst giving stock ratings to ATXI in the past 3 months.

EPS

‪0.00‬
Reported
Estimate
Reported
Estimate
Surprise

Revenue

‪0.00‬
Reported
Estimate
Reported
Estimate
Surprise
Be warned

Frequently Asked Questions

ATXI EPS for the last quarter is 63.75 USD despite the estimation of −7.50 USD. In the next quarter EPS is expected to reach −9.00 USD. Track more of Avenue Therapeutics, Inc. financials and stay on top of what is up with the company.
According to analysts, ATXI price target is 56.25 USD with a max estimate of 56.25 USD and a min estimate of 56.25 USD. Check if this forecast comes true in a year, meanwhile keep track of the current situation with ATXI news and stock market news.